-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
May 01, 2021 - There continues to be no evidence of
increased risk of adverse events for vaccines currently recommended … We documented the observed rates of adverse events and assessed the relative
risks between vaccinated … some observational studies showed increased risk)
Moderate: No evidence of increased risk of asthma … or to
definitively exclude a risk of such adverse events. … Potential risks of rare adverse events should be
weighed against the protective benefits that vaccines
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
April 01, 2020 - nonopioids alone, and opioids
plus nonopioids versus opioids alone at short-term
followup.16 Pooled relative … of overdose; risks
were higher at increased gabapentinoid doses (SOE: low). … of overdose;
risks were higher at increased gabapentinoid doses (SOE: low). … and risks related to opioid use
disorder, was lacking. … Annual Surveillance Report of Drug-Related Risks and
Outcomes--United States, 2017.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
February 01, 2018 - individual trials considered in
meta-analyses
- More likely to be consistent
even with differing baseline
risks … interpretable than OR
Odds Ratio
(OR)
- More likely to be consistent
even with differing baseline
risks … considered in
meta-analyses
- Not easily interpretable
- Can be misleading when interpreted like
relative … risks
- Widespread use in meta-analyses may
be because of convenience and history
rather than an assessment … differ in baseline risk
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
October 01, 2011 - and nonselective) appear to be
associated with increased risk of serious CV risks. … clear
association between longer duration of therapy with
COX-2 selective NSAIDs and increase in the relative … However, because the event rates increases in older
patients, even if the relative risk estimates are … There was
insufficient evidence to evaluate comparative risks of
GI bleeding or CV events. … anti-inflammatory drug; OR = odds ratio; PPI = proton pump inhibitor;
PUD = peptic ulcer disease; RR = relative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
March 01, 2012 - presenting data on
individual endpoints;33
2. selective outcome reporting—for example, reporting relative … Other study designs have specific and inherent risks of biases that
cannot be minimized. … observational studies into
the review and (2) when evaluating individual studies for design-specific risks … In assessing the risk of bias of studies, EPCs
should specify constructs and risks of bias specific … The final domain, “other sources of bias,”
includes design specific risks of bias, baseline imbalance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
January 01, 2012 - risks and 95 percent confidence intervals. … Relative risk reduction was not
significantly different than in similar patients
who did not have microalbuminuria … • Inconsistent data suggested greater relative risk reduction for several clinical
vascular outcomes … Inconsistent results suggested possibly a greater
relative risk reduction with beta blockers in patients … • No RCT data address whether treatments have different
relative risk reduction in clinical outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
May 25, 2021 - The issue is relative
risk. … The relative risk
across all 19 RCTs for which we
could combine data was 0.65 (95%
CI 0.41, 1.05). … For consistency reasons, we have
calculated the relative risk
throughout; in order to calculate the … For consistency reasons, we have
calculated the relative risk
throughout; in order to calculate the … risk to the
vaccine exposure is not presented in
the abstract or how the relative risk
was determined
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - 2: Do specifics of OC use (e.g., dose/formulation, age at initiation, duration of use) affect
the relative … age, family
history of breast and ovarian cancer, BRCA1/BRCA2 mutation status, parity) affect the
relative … and relative risk (or relative risk reduction) for that
outcome in OC users to generate estimates of … risk. … Venous and arterial thrombosis during oral contraceptive use:
risks and risk factors.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-executive-summary.pdf
March 01, 2025 - CHD and digestible carbohydrate intake (per
10% total energy intake increase: relative risk [RR]=1.17 … • Serious risk of bias. … ; RR = relative risk; SOE = strength of evidence
Systematic Review of the Effect of Dietary Digestible … risk. … Abbreviations: %E=percentage of total energy intake; CI = confidence interval; RR = relative risk; SOE
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
November 01, 2008 - However,
placebo-controlled RCTs may also provide important information on absolute and relative risks … 35
There was no clear tendency for randomized trials or
observational studies to report larger relative … risks. … outcomes were more than 0.20.
76
However, the 95-percent confidence intervals for
estimates of relative … risks for these three adverse events encompassed clinically significant
increases in risk (-13.5 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - However,
placebo-controlled RCTs may also provide important information on absolute and relative risks … 35
There was no clear tendency for randomized trials or
observational studies to report larger relative … risks. … outcomes were more than 0.20.
76
However, the 95-percent confidence intervals for
estimates of relative … risks for these three adverse events encompassed clinically significant
increases in risk (-13.5 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - 2: Do specifics of OC use (e.g., dose/formulation,
age at initiation, duration of use) affect the relative … age, family history of
breast and ovarian cancer, BRCA1/BRCA2 mutation
status, parity) affect the relative … Relative risk estimates were
derived from the meta-analyses and other age-specific and
race-specific … Relative Risk of Ovarian Cancer in
OC Users in Subpopulations
Separate meta-analyses were performed … Note that estimates are not adjusted for
competing risks, such as hysterectomy or other-cause
mortality
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01_0.pdf
May 01, 2005 - specific to framing the focus and scope of risk-of-bias assessment; selecting risk of
bias categories … Other
study designs, often included in EPC reviews, have specific and inherent risks of biases that … presenting data on individual endpoints;48 (2) selectively reporting outcomes —for example,
reporting relative … hypothetical trial.61
Selecting and Assessing Relevant Categories of Bias For a Review
Determining the risks … potential biases (e.g., valid randomization and allocation procedures, confounding) and
then focusing on risks
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Treat with a prescription medicine
RISK OF
BLEEDING
ULCER
1 patient out of
100 (1 … Relative Risk
Johnson FR, Ozdemir S, Hauber AB, Kauf T. … Women's willingness to accept risk for perceived vasomotor symptom
relief. … Relative Risk
Johnson FR, Ozdemir S, Hauber AB, Kauf T. … Women's willingness to accept risk for perceived vasomotor symptom
relief.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
April 01, 2013 - Table A shows data on transfusion risk.
3
Table A. Transfusion risk
Variable
Darbepoetin vs. … 1.59) (0.52 to 0.65) (0.51 to 0.65) (0.53 to 0.64)
I2 43% 60% 0% 51%
CI = confidence interval; RR = relative … Epoetin and
darbepoetin conferred similar risks. Table D shows data on
thromboembolic events. … CI = confidence interval; RR = relative risk
5
Rates of thromboembolic events were consistently higher … risk, accompanies their
use.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
August 01, 2007 - was noted that this is an important issue to study in the future.7,8
In the absence of data on the risks … were more likely to
be frail then users of atypical APMs this could result in an overestimation of the relative … In instrumental variable analyses, conventional APMs continued to be associated with greater
risks of … Sensitivity analyses revealed that very large relative risks of 5 or greater would be needed
linking … Simultaneous assessment of short-term
gastrointestinal benefits and cardiovascular risks of
selective
-
effectivehealthcare.ahrq.gov/products/risk-cardiovascular-disease/protocol
-
effectivehealthcare.ahrq.gov/products/high-risk-drugs/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
May 01, 2005 - specific to framing the focus and scope of risk-of-bias assessment; selecting risk of
bias categories … Other
study designs, often included in EPC reviews, have specific and inherent risks of biases that … presenting data on individual endpoints;48 (2) selectively reporting outcomes —for example,
reporting relative … hypothetical trial.61
Selecting and Assessing Relevant Categories of Bias For a Review
Determining the risks … potential biases (e.g., valid randomization and allocation procedures, confounding) and
then focusing on risks
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
January 01, 2023 - dietary carbohydrate index, carbohydrate-fiber ratio, etc.) may play a
major role in altering the risks … Assessment of the Risk of Bias of Individual Studies
We will evaluate the risk of bias of the included … of bias studies versus estimates derived from
studies at low risk of bias. … high and unclear risk of bias studies and not rate down the SOE. … RoB 2: a revised tool for assessing risk of bias in
randomised trials.